Literature DB >> 28801354

Following the fate of endocytosed fibrils.

Masato Hasegawa1, Genjiro Suzuki2.   

Abstract

Cell-to-cell transmission of intracellular protein aggregates is considered a central event in many neurodegenerative diseases, but little is known about the underlying molecular mechanisms. A new study employs fluorescence quenching to examine the fate of α-synuclein, a key molecule in the pathology of Parkinson's disease and related disorders, in primary cultured neurons, finding that endocytosis and lysosomal processing of exogenous fibrils may explain the transmission of α-synuclein pathology.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28801354      PMCID: PMC5555208          DOI: 10.1074/jbc.H117.780296

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies.

Authors:  Richard J Karpowicz; Conor M Haney; Tiberiu S Mihaila; Raizel M Sandler; E James Petersson; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2017-06-13       Impact factor: 5.157

2.  Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.

Authors:  Kelvin C Luk; Victoria Kehm; Jenna Carroll; Bin Zhang; Patrick O'Brien; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

3.  Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes.

Authors:  Yoshinori Tanaka; Genjiro Suzuki; Takashi Matsuwaki; Masato Hosokawa; Geidy Serrano; Thomas G Beach; Keitaro Yamanouchi; Masato Hasegawa; Masugi Nishihara
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

Review 4.  α-Synuclein: Experimental Pathology.

Authors:  Masato Hasegawa; Takashi Nonaka; Masami Masuda-Suzukake
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

5.  Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins.

Authors:  William P Flavin; Luc Bousset; Zachary C Green; Yaping Chu; Stratos Skarpathiotis; Michael J Chaney; Jeffrey H Kordower; Ronald Melki; Edward M Campbell
Journal:  Acta Neuropathol       Date:  2017-05-19       Impact factor: 17.088

6.  Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes.

Authors:  Saïda Abounit; Luc Bousset; Frida Loria; Seng Zhu; Fabrice de Chaumont; Laura Pieri; Jean-Christophe Olivo-Marin; Ronald Melki; Chiara Zurzolo
Journal:  EMBO J       Date:  2016-08-22       Impact factor: 11.598

7.  The Effect of Fragmented Pathogenic α-Synuclein Seeds on Prion-like Propagation.

Authors:  Airi Tarutani; Genjiro Suzuki; Aki Shimozawa; Takashi Nonaka; Haruhiko Akiyama; Shin-Ichi Hisanaga; Masato Hasegawa
Journal:  J Biol Chem       Date:  2016-07-05       Impact factor: 5.157

8.  α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.

Authors:  Joseph R Mazzulli; Friederike Zunke; Ole Isacson; Lorenz Studer; Dimitri Krainc
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-02       Impact factor: 11.205

Review 9.  NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.

Authors:  Michel Goedert
Journal:  Science       Date:  2015-08-07       Impact factor: 47.728

10.  Prion-like spreading of pathological α-synuclein in brain.

Authors:  Masami Masuda-Suzukake; Takashi Nonaka; Masato Hosokawa; Takayuki Oikawa; Tetsuaki Arai; Haruhiko Akiyama; David M A Mann; Masato Hasegawa
Journal:  Brain       Date:  2013-03-06       Impact factor: 13.501

  10 in total
  1 in total

1.  The Herbert Tabor Young Investigator Awards: Meet the awardees!

Authors:  Lila M Gierasch; George DeMartino
Journal:  J Biol Chem       Date:  2018-03-02       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.